Treatment with non-selective beta-blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis.
Gimenez P, Garcia-Martinez I, Francés R, Gonzalez-Navajas JM, Mauri M, Alfayate R, Almenara S, Miralles C, Palazon JM, Carnicer F, Pascual S, Such J, Horga JF, Zapater P.
Gimenez P, et al. Among authors: miralles c.
Liver Int. 2018 Dec;38(12):2219-2227. doi: 10.1111/liv.13890. Epub 2018 Jun 19.
Liver Int. 2018.
PMID: 29802788
Free PMC article.